BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 15327425)

  • 1. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
    Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.
    Mortier S; Faict D; Lameire NH; De Vriese AS
    Kidney Int; 2005 Apr; 67(4):1559-65. PubMed ID: 15780112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; Faict D; Gericke M; Lameire N; De Vriese A
    Nephron Exp Nephrol; 2005; 101(4):e139-45. PubMed ID: 16131808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis.
    Hoshino T; Ishii H; Kitano T; Shindo M; Miyazawa H; Yamada H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Ookawara S; Tabei K; Morishita Y
    Discov Med; 2016 Feb; 21(114):81-8. PubMed ID: 27011043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
    Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
    Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum.
    Oh EJ; Ryu HM; Choi SY; Yook JM; Kim CD; Park SH; Chung HY; Kim IS; Yu MA; Kang DH; Kim YL
    Am J Nephrol; 2010; 31(1):58-67. PubMed ID: 19887789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
    Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
    Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products.
    Mortier S; De Vriese AS; Van de Voorde J; Schaub TP; Passlick-Deetjen J; Lameire NH
    J Am Soc Nephrol; 2002 Feb; 13(2):480-489. PubMed ID: 11805178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; De Vriese AS; McLoughlin RM; Topley N; Schaub TP; Passlick-Deetjen J; Lameire NH
    J Am Soc Nephrol; 2003 May; 14(5):1296-306. PubMed ID: 12707398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.
    Zareie M; Tangelder GJ; ter Wee PM; Hekking LH; van Lambalgen AA; Keuning ED; Schadee-Eestermans IL; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2783-92. PubMed ID: 16204296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.
    Hekking LHP; Zareie M; Driesprong BAJ; Faict D; Welten AGA; de Greeuw I; Schadee-Eestermans IL; Havenith CEG; van den Born J; Ter Wee PM; Beelen RHJ
    J Am Soc Nephrol; 2001 Dec; 12(12):2775-2786. PubMed ID: 11729248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.
    Schwenger V; Morath C; Salava A; Amann K; Seregin Y; Deppisch R; Ritz E; Bierhaus A; Nawroth PP; Zeier M
    J Am Soc Nephrol; 2006 Jan; 17(1):199-207. PubMed ID: 16319192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
    Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
    Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.
    Lai KN; Leung JC; Chan LY; Li FF; Tang SC; Lam MF; Tse KC; Yip TP; Chan TM; Wieslander A; Vlassara H
    Clin Exp Immunol; 2004 Dec; 138(3):466-75. PubMed ID: 15544624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
    Park MS; Kim JK; Holmes C; Weiss MF
    Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.
    Zareie M; van Lambalgen AA; ter Wee PM; Hekking LH; Keuning ED; Schadee-Eestermans IL; Faict D; Degréve B; Tangelder GJ; Beelen RH; van den Born J
    Perit Dial Int; 2005; 25(1):58-67. PubMed ID: 15770927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal dialysis fluid bioincompatibility and new vessel formation promote leukocyte-endothelium interactions in a chronic rat model for peritoneal dialysis.
    Schilte MN; Fabbrini P; Wee PM; Keuning ED; Zareie M; Tangelder GJ; Van Lambalgen AA; Beelen RH; Van Den Born J
    Microcirculation; 2010 May; 17(4):271-80. PubMed ID: 20536740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.